NasdaqGS - Nasdaq Real Time Price USD
PMV Pharmaceuticals, Inc. (PMVP)
0.9030
+0.0260
+(2.95%)
As of 10:44:59 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.68M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MACK DAVID HENRY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.53 per share. | Direct | 58,013 | Jan 3, 2025 |
| JALOTA DEEPIKA Officer | Sale at price 1.50 per share. | Direct | 10,853 | Sep 11, 2024 |
| CARULLI MICHAEL Chief Financial Officer | Sale at price 1.50 per share. | Direct | 4,347 | Sep 11, 2024 |
| MACK DAVID HENRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| JALOTA DEEPIKA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| CARULLI MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.23 per share. | Indirect | 195,763 | Nov 22, 2023 |
| MACK DAVID HENRY Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 10, 2023 |
| MACK DAVID HENRY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.53 per share. | Direct | 105,156 | Oct 18, 2023 |
| ALLAND LEILA Officer | Sale at price 6.62 per share. | Direct | 41,646 | Sep 15, 2023 |
| JALOTA DEEPIKA Officer | Sale at price 6.62 per share. | Direct | 27,168 | Sep 15, 2023 |
| MACK DAVID HENRY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.53 per share. | Direct | 45,315 | Aug 7, 2023 |
Related Tickers
EPIX ESSA Pharma Inc.
1.7200
+0.58%
IKNA Ikena Oncology, Inc.
1.3900
+8.62%
HLVX HilleVax, Inc.
1.9900
+3.12%
LVTX LAVA Therapeutics N.V.
1.3000
+1.16%
ANTX AN2 Therapeutics, Inc.
1.0900
+2.83%
RPTX Repare Therapeutics Inc.
1.4400
+5.11%
IPSC Century Therapeutics, Inc.
0.5506
+1.31%
SEER Seer, Inc.
2.1550
+0.70%
TBPH Theravance Biopharma, Inc.
11.37
+1.93%
NERV Minerva Neurosciences, Inc.
1.6200
+3.85%